$0.7564
-0.13-14.9%
At close: Aug 13, 5:00 PM EST
$0.8120
-0.0768-8.64%
Pre-Market: 4:02 AM EST
Outlook Therapeutics Inc
OTLKNASDAQ
Earnings: Q3 2026 Earnings were released on Fri Aug 14th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 3 days agoClick to view the webcast
Outlook Therapeutics Earnings & Forecasts
Outlook Therapeutics (OTLK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Outlook Therapeutics Guidance
Recent Earnings Results
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.12 | $-0.17 | $-0.24 |
| Actual | $-0.09 | $-0.16 | $-0.22 | $-0.19 |
| Surprise | -12.5% | -33.3% | -29.4% | +20.8% |
| Revenue | ||||
| Estimate | $1.0M | $4.4M | $3.4M | $6.0M |
| Actual | $9000 | $128000 | $-1.2M | $-91787 |
| Surprise | -99.1% | -97.1% | -135.3% | -101.5% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.06 | $-0.05 | $-0.05 | $-0.04 |
| Revenue | ||||
| Consensus | $5.4M | $6.0M | — | — |
